Home / Drug shortages / Emtricitabine Oral Solution

Emtricitabine Oral Solution — FDA Drug Shortage

To Be Discontinued — Gilead Sciences, Inc.

The FDA lists a drug shortage record for Emtricitabine Oral Solution (oral solution) from Gilead Sciences, Inc. with status To Be Discontinued. The shortage was first posted on 06/17/2026.

Shortage Details

Status
To Be Discontinued
Company
Gilead Sciences, Inc.
Package NDC
61958-0602-1
Dosage Form
Oral Solution
Presentation
Emtriva, Oral Solution, 10 mg/1 mL (NDC 61958-0602-1)
Initial Posting
06/17/2026
Revised Date

FDA data resources